000 03863cam a2200565 i 4500
001 9781003365532
003 FlBoTFG
005 20240213122828.0
006 m o d
007 cr cnu---unuuu
008 230210s2023 nyua o 000 0 eng d
040 _aOCoLC-P
_beng
_erda
_epn
_cOCoLC-P
020 _a9781003365532
_q(electronic bk.)
020 _a1003365531
_q(electronic bk.)
020 _a9781000847987
_q(electronic bk. : PDF)
020 _a1000847985
_q(electronic bk. : PDF)
020 _a9781000848007
_q(electronic bk. : EPUB)
020 _a1000848000
_q(electronic bk. : EPUB)
020 _z9781032430546
020 _z1032430540
020 _z9781032430539
020 _z1032430532
024 7 _a10.4324/9781003365532
_2doi
035 _a(OCoLC)1369580822
035 _a(OCoLC-P)1369580822
050 4 _aRD132
072 7 _aBUS
_x070170
_2bisacsh
072 7 _aBUS
_x078000
_2bisacsh
072 7 _aBUS
_x070050
_2bisacsh
072 7 _aMBP
_2bicssc
082 0 4 _a362.10973
_223/eng/20230216
100 1 _aWest, Mark C.,
_eauthor.
245 1 0 _aImplantable medical devices and healthcare affordability :
_bexposing the spiderweb /
_cMark C. West, Michael Georgulis, Jr.
264 1 _aNew York :
_bProductivity Press,
_c2023.
300 _a1 online resource (200 pages) :
_billustrations
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
520 _aThe United States spends more than 17% of its GDP on healthcare, while other developed countries average 8.7% of GDP on healthcare expenditures. All this spending doesn't equate to value, quality, or performance, however. Among 11 high-income countries, the United States healthcare industry ranked last during the past seven years in four key performance categories: administrative efficiency, access to care, equity, and healthcare outcomes. This book presents the implantable medical device (IMD) supply chain ecosystem as a microcosm of how these challenges of affordability and healthcare outcomes are created and are allowed to fester. The IMD Spiderweb, as the authors call it, is exposed as an example of how a wide range of participants--including physicians, health system CEOs, group purchasing organizations, health insurance companies, and supply chain executives--become ensnared in a web designed to benefit only one player. Health systems in the United States pay as much as six times more for some IMDs than their counterparts do in Europe, and prices for the same IMD model vary even among different U.S. hospitals. While there is a fascination with the latest and greatest device, there is also a shroud around visibility into how these products have performed and are likely to perform in patients. The costs continue to rise not only in healthcare expenditures, but also in death and disability. The IMD Spiderweb is presented as a prime lesson in the challenges in healthcare affordability and outcomes that occur throughout the entire healthcare industry. It is also put forward as an opportunity. The story behind how these challenges arose and continue to be deepened by the current healthcare ecosystem also provides a foundation for solutions.
588 _aOCLC-licensed vendor bibliographic record.
650 0 _aImplants, Artificial.
650 0 _aMedical care
_zUnited States.
650 0 _aMedical care, Cost of
_zUnited States.
650 0 _aMedical policy
_zUnited States.
650 7 _aBUSINESS & ECONOMICS / Distribution
_2bisacsh
650 7 _aBUSINESS & ECONOMICS / Industries / Manufacturing Industries
_2bisacsh
700 1 _aGeorgulis, Michael,
_eauthor.
856 4 0 _3Taylor & Francis
_uhttps://www.taylorfrancis.com/books/9781003365532
856 4 2 _3OCLC metadata license agreement
_uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
999 _c5295
_d5295